SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912057-99-010916
Filing Date
1999-12-29
Accepted
1999-12-29 00:00:00
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II,L.P.BIOTECHNOLOGY VALUE FUND L PBIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G/A 18299
2 EXH 99.1 EX-99.1 2159
  Complete submission text file 0000912057-99-010916.txt   22827
Mailing Address 100 BEAVER STREET WALTHAM MA 02154
Business Address 1OO BEAVER ST WALTHAM MA 02154 6178935007
GENOME THERAPEUTICS CORP (Subject) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: SC 13G/A | Act: 34 | File No.: 005-34935 | Film No.: 99782917
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice